Follow The Filings

ATRC AtriCure

AtriCure earnings company data as of 4:45 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS 0.01 — —
Rev $151.2M — —

Insider trades

Open-market buys and sales by ATRC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ATRC insider trades
  • None no insider bought on the open market
  • $3.5M sold by 7 insiders outside a trading plan
  • $880K sold by 1 insider under 10b5-1 plans
  1. Salvatore Privitera Chief Technical Officer
    Planned sale
    $271K 4,519 shares at $60.00 3.1% of stake
    Traded Sep 23 Filed Sep 24
  2. Regina E Groves Director
    Sale
    $288K 5,313 shares at $54.22 13% of stake
    Traded Sep 11 Filed Sep 14
  3. Salvatore Privitera Chief Technical Officer
    Planned sale
    $201K 3,657 shares at $55.00 2.4% of stake
    Traded Sep 8 Filed Sep 10
  4. Salvatore Privitera Chief Technical Officer
    Planned sale
    $408K 7,763 shares at $52.50 4.9% of stake
    Traded Sep 2 Filed Sep 4
  5. Karl S. Dahlquist Chief Legal Officer
    Sale
    $458K 9,370 shares at $48.89 9.7% of stake
    Traded Aug 24 Filed Aug 26
  6. Maggie Yuen Director
    Sale
    $134K 3,500 shares at $38.42 20% of stake
    Traded Aug 5 Filed Aug 7
  7. Karen Prange Director
    Sale
    $138K 3,564 shares at $38.80 14% of stake
    Traded Aug 5 Filed Aug 7
  8. Vinayak Doraiswamy Chief Scientific Officer
    Sale
    $233K 6,000 shares at $38.88 6.5% of stake
    Traded Jul 28 Filed Jul 30
  9. Justin J Noznesky Chief Mktg & Strategy Officer
    Sale
    $240K 6,182 shares at $38.80 5.8% of stake
    Traded Jul 29 Filed Jul 30
  10. Sven Wehrwein Director
    Sale
    $946K 25,000 shares at $37.84 38% of stake
    Traded Jul 28 Filed Jul 30
  11. Karen Prange Director
    Sale
    $86K 3,000 shares at $28.65 10% of stake
    Traded May 20 Filed May 22
  12. Vinayak Doraiswamy Chief Scientific Officer
    Sale
    $141K 5,000 shares at $28.13 5.2% of stake
    Traded May 15 Filed May 18
  13. Vinayak Doraiswamy Chief Scientific Officer
    Sale
    $149K 5,000 shares at $29.83 4.9% of stake
    Traded Mar 12 Filed Mar 16
  14. Justin J Noznesky Chief Mktg & Strategy Officer
    Sale
    $193K 5,166 shares at $37.29 6.2% of stake
    Traded Nov 26, 2025 Filed Nov 26, 2025
  15. Sven Wehrwein Director
    Sale
    $377K 10,000 shares at $37.66 23% of stake
    Traded Nov 24–25 Filed Nov 26, 2025

Also filed in the last 12 months, not counted as buying or selling: 28 stock grants, 7 share withholdings for taxes, 6 gifts, and 4 option exercises.

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 5.02,5.07,9.01
SCHEDULE 13G/A —
8-K/A 2.02,9.01
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G —
DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf